Open Access. Powered by Scholars. Published by Universities.®

Food and Drug Law Commons

Open Access. Powered by Scholars. Published by Universities.®

2020

Discipline
Institution
Keyword
Publication
Publication Type

Articles 121 - 150 of 194

Full-Text Articles in Food and Drug Law

Recommendations For Addressing Environmental Impact Of African Development Projects Funded By Chinese Banks, Tais Ludwig Mar 2020

Recommendations For Addressing Environmental Impact Of African Development Projects Funded By Chinese Banks, Tais Ludwig

Sustainable Development Law & Policy

No abstract provided.


Preventing A Renewable Resource Curse, Scott W. Lyons Mar 2020

Preventing A Renewable Resource Curse, Scott W. Lyons

Sustainable Development Law & Policy

No abstract provided.


Editor's Note, Jacqueline Niba Mar 2020

Editor's Note, Jacqueline Niba

Sustainable Development Law & Policy

No abstract provided.


Notas A Pie De Página, Sustainable Development Law & Policy Mar 2020

Notas A Pie De Página, Sustainable Development Law & Policy

Sustainable Development Law & Policy

No abstract provided.


El Crecimiento De La Justicia Ambiental Y De Protección Del Medio Ambiente En El Derecho Internacional: En El Contexto De La Regulación De Petróleo Submarino De La Industria De Ártico, E.A. Barry-Pheby Mar 2020

El Crecimiento De La Justicia Ambiental Y De Protección Del Medio Ambiente En El Derecho Internacional: En El Contexto De La Regulación De Petróleo Submarino De La Industria De Ártico, E.A. Barry-Pheby

Sustainable Development Law & Policy

No abstract provided.


Consentimiento Libre, Previo E Informado: Implicaciones Para Las Empresas Transnacionales, Tendai Zvobgo Mar 2020

Consentimiento Libre, Previo E Informado: Implicaciones Para Las Empresas Transnacionales, Tendai Zvobgo

Sustainable Development Law & Policy

No abstract provided.


Financiamiento Musulmán Como Un Mecanismo Para Reforzar La Seguridad Alimentaria En El Medio Oriente: Seguridad Alimentaria Waqf, Hdeel Abdelhady Mar 2020

Financiamiento Musulmán Como Un Mecanismo Para Reforzar La Seguridad Alimentaria En El Medio Oriente: Seguridad Alimentaria Waqf, Hdeel Abdelhady

Sustainable Development Law & Policy

No abstract provided.


El Débil Proceso De Planificatión Frustra La Protección De La Amenazda Línea Costera De Puerto Rico, Mark Borak Mar 2020

El Débil Proceso De Planificatión Frustra La Protección De La Amenazda Línea Costera De Puerto Rico, Mark Borak

Sustainable Development Law & Policy

No abstract provided.


Una Norma Legal Por La Reforma Agraria Poscolonial, Amelia Chizwala Peterson Mar 2020

Una Norma Legal Por La Reforma Agraria Poscolonial, Amelia Chizwala Peterson

Sustainable Development Law & Policy

No abstract provided.


Colaboración Y La Ecologia De La Democracia, Daniel Kemmis, Matthew Mckinney Mar 2020

Colaboración Y La Ecologia De La Democracia, Daniel Kemmis, Matthew Mckinney

Sustainable Development Law & Policy

No abstract provided.


Crisis Del Agua En La Cuenca De Murray-Darling: Australia Intenta Equilibrar La Necesidad Agricola Con La Realidad Ambiental, Joshua Axelrod Mar 2020

Crisis Del Agua En La Cuenca De Murray-Darling: Australia Intenta Equilibrar La Necesidad Agricola Con La Realidad Ambiental, Joshua Axelrod

Sustainable Development Law & Policy

No abstract provided.


Los Recursos Naturales De Alto Valor: ¿Una Bendición O Una Maldición Para La Paz?, Päivi Lujala, Siri Aas Rustad Mar 2020

Los Recursos Naturales De Alto Valor: ¿Una Bendición O Una Maldición Para La Paz?, Päivi Lujala, Siri Aas Rustad

Sustainable Development Law & Policy

No abstract provided.


Dejarles En Bancarrota A Los Saqueadores De Paz: ¿Cuál Es El Rol De Las Fuerzas De Paz De La Onu?, Philippe Le Billon Mar 2020

Dejarles En Bancarrota A Los Saqueadores De Paz: ¿Cuál Es El Rol De Las Fuerzas De Paz De La Onu?, Philippe Le Billon

Sustainable Development Law & Policy

No abstract provided.


Nota Del Los Editores, Veronica Kennedy, Jocelyn Rivera Mar 2020

Nota Del Los Editores, Veronica Kennedy, Jocelyn Rivera

Sustainable Development Law & Policy

No abstract provided.


Faculty Profiles, David Newman Mar 2020

Faculty Profiles, David Newman

Sustainable Development Law & Policy

No abstract provided.


Coral Reefs In The Philippines, Maggie Parks Mar 2020

Coral Reefs In The Philippines, Maggie Parks

Sustainable Development Law & Policy

No abstract provided.


Practitioner's Corner: Ken Markowitz On Serving As An Environmental Advocate, Kimberly Righter Mar 2020

Practitioner's Corner: Ken Markowitz On Serving As An Environmental Advocate, Kimberly Righter

Sustainable Development Law & Policy

No abstract provided.


2001 Supreme Court Redux, Mary Stevens Mar 2020

2001 Supreme Court Redux, Mary Stevens

Sustainable Development Law & Policy

No abstract provided.


Next Verse, Same As The First: Inadequacies In The Government's Legal Approach Toward Biotechnology, Kimberly Righter Mar 2020

Next Verse, Same As The First: Inadequacies In The Government's Legal Approach Toward Biotechnology, Kimberly Righter

Sustainable Development Law & Policy

No abstract provided.


Implementing Kyoto, Glenn Wiser Mar 2020

Implementing Kyoto, Glenn Wiser

Sustainable Development Law & Policy

No abstract provided.


Regulating Medicines In A Globalized World With Increased Recognition And Reliance Among Regulators: A National Academies Report, Lawrence O. Gostin, Alastair J. Wood, Patricia A. Cuff Mar 2020

Regulating Medicines In A Globalized World With Increased Recognition And Reliance Among Regulators: A National Academies Report, Lawrence O. Gostin, Alastair J. Wood, Patricia A. Cuff

Georgetown Law Faculty Publications and Other Works

Research and development of pharmaceuticals are now complex global endeavors, with drug companies operating worldwide using global supply chains. Pharmaceutical companies source their products from many countries, conduct trials in multiple sites, and market essential drugs and vaccines globally. Yet oversight of drug safety and effectiveness is primarily the responsibility of national regulators of variable capacities. National agencies often undertake product reviews without recognizing that similar reviews are occurring elsewhere, sometimes simultaneously. The result is duplication and redundancy, which benefits neither national nor global public health. Supported by the US Food and Drug Administration (FDA), the National Academies of Sciences, …


The Cost Of Novelty, Will Nicholson Price Ii Mar 2020

The Cost Of Novelty, Will Nicholson Price Ii

Articles

Patent law tries to spur the development of new and better innova­tive technology. But it focuses much more on “new” than “better”—and it turns out that “new” carries real social costs. I argue that patent law promotes innovation that diverges from existing technology, either a little (what I call “differentiating innovation”) or a lot (“exploring innova­tion”), at the expense of innovation that tells us more about existing technology (“deepening innovation”). Patent law’s focus on newness is unsurprising, and fits within a well-told narrative of innovative diversity accompanied by market selection of the best technologies. Unfortunately, innovative diversity brings not only …


The Doctrine Of Wilful Blindness In Drug Offences: Adili Chibuike Ejike V Public Prosecutor [2019] 2 Slr 254, Rennie Whang Mar 2020

The Doctrine Of Wilful Blindness In Drug Offences: Adili Chibuike Ejike V Public Prosecutor [2019] 2 Slr 254, Rennie Whang

Research Collection Yong Pung How School Of Law

In Adili Chibuike Ejike v Public Prosecutor [2019] 2 SLR 254, the Court of Appeal clarified the operation of the wilful blindness doctrine in the context of knowing possession for drug offences. In particular, it affirmed wilful blindness as a doctrine of substantive rather than evidential law, which applies as a limited extension to the legal requirement of actual knowledge. The court then articulated a three-part test for the finding of wilful blindness in relation to knowledge as an ingredient of possession. However, it left open the content of the doctrine as applied to the element of knowledge in drug …


The Ip Of Ipas, Stephen Wolfson, Brian Roth, Chase Scott, Dustin Watts, Charles Hicks, Shivani Patel Feb 2020

The Ip Of Ipas, Stephen Wolfson, Brian Roth, Chase Scott, Dustin Watts, Charles Hicks, Shivani Patel

Other Colloquium, Conferences, and Symposia

Hosted by the Journal of Intellectual Property Law, this panel brought Brian Roth (Southern Brewing Co.), Chase Scott (Taylor, Feil, Harper & Lumsden, P.C.), and Dustin Watts (Terrapin Beer Co.) together with Stephen Wolfson (Research & Copyright Services Librarian, UGA Law School) and students from the Journal of Intellectual Property Law to discuss how breweries are navigating intellectual property issues. Free koozies to commemorate the event were distributed.


Voluntary Licensing Of Pharmaceuticals: The Strategy Against Compulsory Licensing, Daniel D. Kim Feb 2020

Voluntary Licensing Of Pharmaceuticals: The Strategy Against Compulsory Licensing, Daniel D. Kim

Intellectual Property Brief

No abstract provided.


Non-Transparent Pbm Cash Flows: Balancing Market Forces Under A Reluctant Legislative Regime, John Mcguinness Feb 2020

Non-Transparent Pbm Cash Flows: Balancing Market Forces Under A Reluctant Legislative Regime, John Mcguinness

William & Mary Business Law Review

No abstract provided.


Fighting America’S Best-Selling Product: An Analysis Of And Solution To The Opioid Crisis, Ashley Duckworth Jan 2020

Fighting America’S Best-Selling Product: An Analysis Of And Solution To The Opioid Crisis, Ashley Duckworth

Washington and Lee Journal of Civil Rights and Social Justice

Deaths from drug overdoses have doubled over the last ten years and are now the leading cause of accidental death in the United States. Although some overdoses may have involved more than one drug, prescription and/or illicit opioids were involved in many of these drug overdose fatalities. The Food and Drug Administration (FDA), Center for Disease Control and Prevention (CDC), and Congress have enacted a string of regulations, statutes, and programs since the early 1990s, but nothing has seriously improved the opioid epidemic as it stands. If anything, the use of opioids has persisted. Many people want pharmaceutical companies to …


The Budding Hemp Industry: The Effect Of Texas House Bill 1325 On Employment Drug Policies, Meina Heydari Jan 2020

The Budding Hemp Industry: The Effect Of Texas House Bill 1325 On Employment Drug Policies, Meina Heydari

Student Scholarship

Contemporary attitudes toward cannabis use in the United States have shifted from War on Drugsera prohibition toward decriminalization over the past two decades. As states that do not seek to decriminalize marijuana nonetheless enact legislation legalizing CBD, policy tensions arise. In 2019, Texas joined the ranks of states that legalized hemp and hemp-derived products with the passage of House Bill 1325. In light of this legislation, this Article discusses the implications of legalized cannabidiol (CBD) on employment drug policies in Texas. The benefits of CBD legalization must be weighed against the practical implications to effectively balance policies that aim to …


Why The Dea & Not The Fda? Revisiting The Regulation Of Potentially Addictive Substances, Taleed El-Sabawi Jan 2020

Why The Dea & Not The Fda? Revisiting The Regulation Of Potentially Addictive Substances, Taleed El-Sabawi

Faculty Publications

In addressing the opioid overdose crisis, Congress has explicitly questioned its historic reliance on a criminal justice approach to problem drug use and has instead adopted a more health-oriented approach. Despite Congress' rhetoric, the DEA, a criminal justice agency, continues to retain the power to make key decisions on the classification of potentially-addictive substances, thereby affecting their manufacture, distribution, and overall availability. While the DEA is statutorily required to defer to the Food and Drug Administration (“FDA”), a public health agency, at junctions of the decision-making process, the current “split enforcement” scheme laid out in the statutes has not actualized …


Illegitimate Medical Purpose: Resolving The Fundamental Flaw In Criminal Prosecutions Involving Physicians Charged With Overprescribing Prescription Opioids, Jacob C. Hanley Jan 2020

Illegitimate Medical Purpose: Resolving The Fundamental Flaw In Criminal Prosecutions Involving Physicians Charged With Overprescribing Prescription Opioids, Jacob C. Hanley

Duquesne Law Review

No abstract provided.